China Pharma Holdings Inc

CPHI05 Dec 2024
Healthcare
$0.21
-0.03 (-3.31%)
Lowest Today
$0.18
Highest Today
$0.21
Today’s Open
$0.21
Prev. Close
$0.2
52 Week High
$0.69
52 Week Low
$0.17
To Invest in China Pharma Holdings Inc

China Pharma Holdings Inc

Healthcare
CPHI05 Dec 2024
-0.03 (-3.31%)
1M
3M
6M
1Y
5Y
Low
$0.18
Day’s Range
High
$0.21
0.18
52 Week Low
$0.17
52-Week Range
52 Week High
$0.69
0.17
1 Day
-
1 Week
-
1 month return
-20.31%
3 month return
+0.35%
6 month return
-29%
1 Year return
-69.96%
3 Years return
-99.16%
5 Years return
-98.28%
10 Years return
-
Fundamentals
Market Cap
3.69 mln
PB Ratio
0.66
PE Ratio
0
Enterprise Value
8.8 mln
Total Assets
16.47 mln
Volume

Company Financials

Fund house & investment objective

Company Information
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
Organisation
China Pharma Holdings Inc
Employees
231
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Zhilin  Li
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities